References
- Fox CB, Kramer RM, Barnes VL, Dowling QM, Vedvick TS. Working together: interactions between vaccine antigens and adjuvants. Ther Adv Vaccines 2013; 1:7 - 20
- Christensen D, Henriksen-Lacey M, Kamath AT, Lindenstrøm T, Korsholm KS, Christensen JP, et al. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J Control Release 2012; 160:468 - 76; http://dx.doi.org/10.1016/j.jconrel.2012.03.016; PMID: 22709414
- Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P, et al. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release 2010; 145:102 - 8; http://dx.doi.org/10.1016/j.jconrel.2010.03.027; PMID: 20381556
- Andersen CA, Rosenkrands I, Olsen AW, Nordly P, Christensen D, Lang R, et al. Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guérin. J Immunol 2009; 183:2294 - 302; http://dx.doi.org/10.4049/jimmunol.0804091; PMID: 19620310
- Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, Goldsmith PK, et al. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 2011; 186:2422 - 9; http://dx.doi.org/10.4049/jimmunol.1002845; PMID: 21242525
- Pant GR, Horton DL, Dahal M, Rai JN, Ide S, Leech S, et al. Characterization of rabies virus from a human case in Nepal. Arch Virol 2011; 156:681 - 4; http://dx.doi.org/10.1007/s00705-010-0868-9; PMID: 21298457